Skip to content
Disclosery

Blackcrane Capital, LLC

Follow

13F filer, CIK 1720745, BELLEVUE, WA

Blackcrane Capital, LLC reported $42,859,000 across 8 holdings for the quarter ended 2020-09-30, in a 13F-HR filed 2020-11-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001720745-20-000005

Period
2020-09-30
Reported value
$42.9M
Holdings
8
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PROFadded+21,623$381K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AXONICS INCreduced-303,572-$15.5M
RCELreduced-446,681-$11.2M
ONCOCYTE CORPexited-2,982,557-$5.7M
WIXreduced-20,769-$5.29M
BIOHAVEN PHARMACEUTICAL HOL…reduced-78,753-$5.12M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2020

Share positions as resolved from 13F-HR 0001720745-20-000005, largest first. % of portfolio is the value over $42,859,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RCELAVITA MEDICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 921,663 shares; 2020Q3: 474,982 shares 474,982$12M27.88%-446,681Timeline
WIXWIX COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 62,379 shares; 2020Q3: 41,610 shares 41,610$10.6M24.74%-20,769Timeline
AXONICS INCAXONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 428,359 shares; 2020Q3: 124,787 shares 124,787$6.37M14.86%-303,572
NICENICE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 43,657 shares; 2020Q3: 25,952 shares 25,952$5.89M13.75%-17,705Timeline
PROFPROFOUND MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 175,301 shares; 2020Q3: 196,924 shares 196,924$3.47M8.11%+21,623Timeline
BIOHAVEN PHARMACEUTICAL HOL…BIOHAVEN PHARMACEUTICAL HOLDINQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 122,865 shares; 2020Q3: 44,112 shares 44,112$2.87M6.69%-78,753
MSFTMICROSOFT CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 14,039 shares; 2020Q3: 5,904 shares 5,904$1.24M2.9%-8,135Timeline
TAKTAKEDA PHARMACEUTICAL CO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 25,723 shares; 2020Q3: 25,723 shares 25,723$459K1.07%0Timeline

Sold out in Q3 2020

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ONCOCYTE CORPONCOCYTE CORP2,982,557$5.7Mshares

How Q3 2020 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001720745-20-000005 base2020-11-12acceptance time not in the bulk data set